We are live on ! Find out more
AXDX

Accelerate Diagnostics

Delisted

AXDX was delisted on the 14th of May, 2025.

71 hedge funds and large institutions have $232M invested in Accelerate Diagnostics in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 20

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

9% less call options, than puts

Call options by funds: $3.51M | Put options by funds: $3.86M

5% less funds holding

Funds holding: 7571 (-4)

13% less capital invested

Capital invested by funds: $265M → $232M (-$33.3M)

33% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 12

Holders
71
Holders Change
-4
Holders Change %
-5.33%
% of All Funds
2.06%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
8
Increased
31
Reduced
20
Closed
12
Calls
$3.51M
Puts
$3.86M
Net Calls
-$353K
Net Calls Change
+$2.5M

AXDX Hedge Fund Activity: Q3 2014 in Review

71 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q3 2014, worth a combined $232M — down 13% from $265M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of AXDX and 8 opened new positions — a net loss of 4 holders — while 20 trimmed existing stakes and 31 added.

The largest buyer was Miura Global Management, opening a new position worth an estimated $4.86M. The largest seller was Jane Street, exiting entirely with an estimated $3.12M sold.

  • 71 institutional investors held Accelerate Diagnostics (AXDX) as of Q3 2014, down from 75 in Q2 2014.
  • Funds reported $232M of Accelerate Diagnostics stock for Q3 2014, down 13% quarter-over-quarter.
  • 8 funds opened new Accelerate Diagnostics positions in Q3 2014 and 12 closed out, a net change of -4 holders.
  • The largest Accelerate Diagnostics buyer in Q3 2014 was Miura Global Management, an estimated $4.86M added.
  • The largest Accelerate Diagnostics seller in Q3 2014 was Jane Street, an estimated $3.12M sold.

Based on aggregated 13F filings for Q3 2014.